The median serum adiponectin level was 17.6 (interquartile range: IQR, 11.7–24.5) μg/mL, which is approximately 3-fold higher than the reported value of 5.4 ± 2.3 μg/mL in non-CKD male subjects10. Here, ADIPOQ is linked to chronic kidney disease.